Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European stocks lower; banking worries continue to weigh

Published 04/26/2023, 03:54 AM
Updated 04/26/2023, 04:10 AM
© Reuters.

Investing.com - European stock markets traded lower Wednesday, with worries about the health of the global banking system weighing as the earnings season continues at a pace.

At 03:55 ET (07:55 GMT), the DAX index in Germany traded 1% lower, the CAC 40 in France dropped 1.1%, and the FTSE 100 in the U.K. fell 0.6%.

Standard Chartered (LON:STAN) was the latest European lender to release results earlier Wednesday, and the British bank posted a 21% rise in pretax profit, ahead of estimates, helping its stock to rise 0.5%.

However, the sector as a whole traded in the red after Swiss lender UBS (SIX:UBSG) and Spain’s Santander (BME:SAN), the eurozone’s second-biggest lender in terms of market value, disappointed the markets with their quarterly earnings results on Tuesday.

Additionally, the Swiss financial regulator FINMA questioned the crisis plans of two of the country's five systemically important banks–Zuercher Kantonalbank and PostFinance–calling their emergency blueprints insufficient.

Across the pond, First Republic Bank (NYSE:FRC) stock slumped after revealing $100 billion in customer withdrawals last month, fueling concerns for the whole U.S. regional banking sector. 

Away from the financial sector, Danone (EPA:DANO) stock rose 0.8% after the global foods giant raised its 2023 sales growth outlook after it reported higher-than-expected first-quarter revenue.

GSK (LON:GSK) stock fell 0.6% after the U.K. drugmaker said it expected adjusted operating profit growth to be lower in the first half of the year as costs increase to fuel expected drug launches, even as it reaffirmed its guidance for 2023.

Puma (ETR:PUMG) stock fell 2.7% after the German sportswear maker said it expected second-quarter sales to grow at a low- to mid-single-digit percentage rate, below its full-year target, citing high inventory levels and ongoing challenges in the market.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Roche (SIX:RO) stock fell 1.4% after the Swiss healthcare company reported a 7% drop in first-quarter sales on falling demand for its COVID-19 therapies and diagnostics kits.

Equity markets had received a boost overnight as first-quarter results from U.S. tech giants Microsoft (NASDAQ:MSFT) and Google owner Alphabet (NASDAQ:GOOGL), released after the closing bell on Wall Street, beat market expectations.

On the economic data front, the forward-looking German GfK consumer sentiment index came in at -25.7 for May, an improvement from the revised prior reading of -29.3, and the seventh rise in a row.

There are also a number of ECB policymakers scheduled to speak later in the session, including Andrea Enria, Kerstin af Jochnick and Luis De Guindos, who could offer clues as to the future path of the central bank’s monetary policy.

The European Central Bank is widely expected to lift interest rates again in early May, with the main open question being the size of the move, a quarter- or a half-point step.

Oil prices stabilized Wednesday after the previous session’s sharp losses, helped by falling U.S. fuel inventories pointing to resilient demand in the world’s largest oil consumer. 

Data from the American Petroleum Institute, released late Tuesday, showed that U.S. crude inventories fell by just over 6 million barrels last week, more than the expected 1.7 million barrels, while gasoline inventories fell 1.9 million barrels.

By 03:55 ET, U.S. crude futures traded 0.2% higher at $77.21 a barrel, while the Brent contract edged higher to $80.62.

Additionally, gold futures rose 0.2% to $2,008.40/oz, while EUR/USD traded 0.4% higher at 1.1019.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Everytime this page types an article the opposite happens within hours. Smh.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.